Breaking News Instant updates and real-time market news.

GOVX

GeoVax Labs

$0.00

(0.00%)

09:05
11/14/19
11/14
09:05
11/14/19
09:05

GeoVax Labs to present at Vaccines R&D Conference

GeoVax Labs announced that its Chief Scientific Officer, Farshad Guirakhoo, PhD, will be a featured speaker at the Vaccines Research and Development conference, being held November 18-20, 2019 in Boston, Massachusetts. Dr. Guirakhoo will co-chair a session on infectious diseases, during which he will deliver a presentation entitled, MVA as a Safe and Effective Platform for Delivery of Multi-Antigen Vaccine Candidates for Infectious Diseases and Cancer. During the conference, Dr. Guirakhoo will also serve as a panelist for a session discussing the development of vaccines for the current Ebola crisis. GeoVax's Modified Vaccinia Ankara platform technology is built on a 5th generation MVA vector system that is improved for high expression and stable transgenes during manufacture. Similar to its parent MVA, it has the advantages of being a live replication-competent vector in avian cells for manufacturing, yet replication-deficient in mammalian cells for vaccination, thus inherently safe. Importantly, MVA vaccines elicit protective T cell as well as antibody responses in animals and humans. The GeoVax MVA platform can be combined with the potent immunogenicity of Virus Like Particles or be used to express proteins in their native conformations, enabling construction of vaccine candidates that induce full protection after a single dose. Built upon this platform, GeoVax's preventive HIV vaccine has demonstrated robust and durable immune responses in clinical trials involving more than 500 subjects. Single-dose protection is a favourable characteristic of a vaccine for emerging infectious disease outbreak response, given the speed of spread of pathogens and the impracticality of multi-dose regimens in the under-resourced settings where outbreaks often occur. MVA-VLP vaccine candidates against various virus families induced strong antibody and T cell responses and demonstrated broad protections after single dose vaccinations against lethal challenges. In his presentation, Dr. Guirakhoo will discuss the utility of the platform not only against emerging and re-emerging pathogens but also against cancer or chronic infectious diseases such as HBV, HPV and malaria.

TODAY'S FREE FLY STORIES

AMAT

Applied Materials

$56.60

0.77 (1.38%)

06:59
12/09/19
12/09
06:59
12/09/19
06:59
Conference/Events
Applied Materials management to meet with UBS »

Breakfast Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CGC

Canopy Growth

$18.65

0.07 (0.38%)

, STZ

Constellation Brands

$183.60

1.13 (0.62%)

06:58
12/09/19
12/09
06:58
12/09/19
06:58
Recommendations
Cantor sees over 66% chance of Constellation bidding for Canopy Growth »

Cantor Fitzgerald analyst…

CGC

Canopy Growth

$18.65

0.07 (0.38%)

STZ

Constellation Brands

$183.60

1.13 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

MTG

MGIC Investment

$14.10

-0.03 (-0.21%)

06:58
12/09/19
12/09
06:58
12/09/19
06:58
Hot Stocks
MGIC Investment issues November operating statistics »

MGIC Investment issued an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ZION

Zions Bancorp

$49.71

0.43 (0.87%)

06:56
12/09/19
12/09
06:56
12/09/19
06:56
Conference/Events
Zions Bancorp management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

EGRX

Eagle Pharmaceuticals

$56.38

0.85 (1.53%)

06:55
12/09/19
12/09
06:55
12/09/19
06:55
Hot Stocks
Eagle Pharmaceuticals commences dosing in pilot study of fulvestrant »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YY

YY

$58.68

-0.7 (-1.18%)

06:54
12/09/19
12/09
06:54
12/09/19
06:54
Conference/Events
YY management to meet with Benchmark »

Group Breakfast Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

THO

Thor Industries

$67.76

2.17 (3.31%)

06:54
12/09/19
12/09
06:54
12/09/19
06:54
Earnings
Thor Industries reports Q1 EPS 92c, consensus $1.23 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

WTER

Alkaline Water

$1.13

0.01 (0.89%)

06:51
12/09/19
12/09
06:51
12/09/19
06:51
Conference/Events
Alkaline Water management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

FTV

Fortive

$72.86

0.5 (0.69%)

06:50
12/09/19
12/09
06:50
12/09/19
06:50
Upgrade
Fortive rating change  »

Fortive upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

MRK

Merck

$88.84

0.09 (0.10%)

, ARQL

ArQule

$9.67

0.15 (1.58%)

06:49
12/09/19
12/09
06:49
12/09/19
06:49
Hot Stocks
Merck to acquire ArQule for $20 per share, or approximately $2.7B »

Merck (MRK) and ArQule…

MRK

Merck

$88.84

0.09 (0.10%)

ARQL

ArQule

$9.67

0.15 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 11

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

COLD

Americold Realty Trust

$37.09

-0.31 (-0.83%)

06:49
12/09/19
12/09
06:49
12/09/19
06:49
Downgrade
Americold Realty Trust rating change  »

Americold Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETNB

89bio

$28.38

0.86 (3.13%)

06:48
12/09/19
12/09
06:48
12/09/19
06:48
Initiation
89bio initiated  »

89bio initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$151.77

1.85 (1.23%)

, DELL

Dell Technologies

$47.09

-0.255 (-0.54%)

06:48
12/09/19
12/09
06:48
12/09/19
06:48
Periodicals
China orders state offices to remove foreign hardware, software, FT reports »

China's Communist…

MSFT

Microsoft

$151.77

1.85 (1.23%)

DELL

Dell Technologies

$47.09

-0.255 (-0.54%)

HPQ

HP Inc.

$20.50

0.17 (0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 27

    Feb

WCC

Wesco

$55.24

1.14 (2.11%)

06:48
12/09/19
12/09
06:48
12/09/19
06:48
Conference/Events
Wesco management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 11

    Dec

CRVS

Corvus Pharmaceuticals

$4.26

-0.36 (-7.79%)

06:46
12/09/19
12/09
06:46
12/09/19
06:46
Recommendations
Corvus Pharmaceuticals analyst commentary  »

Corvus pipeline updates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRL

Charles River

$146.23

1.765 (1.22%)

06:45
12/09/19
12/09
06:45
12/09/19
06:45
Recommendations
Charles River analyst commentary  »

Charles River price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY-R

Bristol-Myers Squibb CVR

$0.00

(0.00%)

, BMY

Bristol-Myers

$59.94

0.435 (0.73%)

06:42
12/09/19
12/09
06:42
12/09/19
06:42
Recommendations
Bristol-Myers Squibb CVR, Bristol-Myers analyst commentary  »

Bristol-Myers Squibb CVR…

BMY-R

Bristol-Myers Squibb CVR

$0.00

(0.00%)

BMY

Bristol-Myers

$59.94

0.435 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 11

    Dec

MRNS

Marinus Pharmaceuticals

$1.32

0.06 (4.76%)

06:39
12/09/19
12/09
06:39
12/09/19
06:39
Hot Stocks
Marinus Pharmaceuticals provides update on orphan seizure programs »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOW

Dow Inc.

$53.25

1.24 (2.38%)

06:39
12/09/19
12/09
06:39
12/09/19
06:39
Upgrade
Dow Inc. rating change  »

Dow Inc. upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRA

Kraton

$23.04

0.63 (2.81%)

06:39
12/09/19
12/09
06:39
12/09/19
06:39
Upgrade
Kraton rating change  »

Kraton upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STZ

Constellation Brands

$183.60

1.13 (0.62%)

, CGC

Canopy Growth

$18.65

0.07 (0.38%)

06:38
12/09/19
12/09
06:38
12/09/19
06:38
Hot Stocks
Constellation Brands appoints Garth Hankinson as CFO »

Constellation Brands…

STZ

Constellation Brands

$183.60

1.13 (0.62%)

CGC

Canopy Growth

$18.65

0.07 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

VIAC

ViacomCBS

$39.70

-1.08 (-2.65%)

06:38
12/09/19
12/09
06:38
12/09/19
06:38
Initiation
ViacomCBS initiated  »

ViacomCBS reinstated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THC

Tenet

$35.53

1.255 (3.66%)

06:37
12/09/19
12/09
06:37
12/09/19
06:37
Upgrade
Tenet rating change  »

Tenet upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$18.65

0.07 (0.38%)

, STZ

Constellation Brands

$183.60

1.13 (0.62%)

06:37
12/09/19
12/09
06:37
12/09/19
06:37
Hot Stocks
Canopy Growth appoints David Klein as CEO »

Canopy Growth (CGC)…

CGC

Canopy Growth

$18.65

0.07 (0.38%)

STZ

Constellation Brands

$183.60

1.13 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

GM

General Motors

$35.54

0.23 (0.65%)

06:35
12/09/19
12/09
06:35
12/09/19
06:35
Periodicals
Avtovaz to buy out GM from Russia JV, Reuters reports »

Russia's Avtovaz…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.